Michael O’Leary, Kate Lien and Duncan Gratton Represented Duffy Properties
Cushman & Wakefield today announced it has represented Duffy Properties, a real estate development and management company, in its lease of 45 Hartwell Ave. in Lexington, MA. The full building, a 50,578-square-foot space, has been leased by Brammer Bio, LLC, a contract development and manufacturing organization (CDMO) serving companies seeking to develop and commercialize cell and gene therapies. The space will be used for Brammer Bio’s operations team.
Cushman & Wakefield Senior Vice President Michael O’Leary, Vice President Kate Lien and Executive Managing Director Duncan Gratton represented Duffy Properties in the transaction, while CBRE Senior Vice President and Partner Curtis Cole and Vice President Alex Plaisted represented Brammer Bio.
“After its recent merger, Brammer Bio needed a space that would allow it to continue recruiting new clients and build relationships with existing clients,” said Steve Duffy, principal of Duffy Properties. “I look forward to watching as Brammer Bio continues to meet the development and manufacturing needs of the cell and gene therapy market from this location.”
Situated just 20 miles from downtown Boston, 45 Hartwell Ave. is near Routes 4 and 255 directly off Route 128, with easy access to I-93 and the Mass Pike. It is minutes away from Hanscom Air Force Base, with area amenities including the Burlington Mall, Boston Sports Club and many restaurants. The property is the former home of Synta Pharmaceuticals.
“Lexington has become a biotech hub in recent years, making it a fitting home for Brammer Bio’s operations team,” O’Leary said. “This location’s proximity to Boston and Kendall Square will allow Brammer Bio to easily connect with clients in both the city and the suburbs.”
About Brammer Bio, LLC
Brammer Biopharmaceuticals LLC was founded early in 2015 to create a best-in-class cell and gene therapy contract development and manufacturing organization (CDMO) to enable large pharma and biotech clients to accelerate the delivery of novel medicines to improve patient health. With the in-depth biologics manufacturing knowledge and expertise of founders Mark Bamforth (CEO) and Steven Kasok (CFO), previously cofounders of Gallus Biopharmaceuticals, now as Brammer Bio, the company is positioned to accelerate the development of these important emerging technologies. The company is building-out a facility in Lexington, MA, to meet the development and manufacturing needs of the cell and gene therapy market. Visitwww.brammerbio.com.
About Duffy Properties
Duffy Properties is a commercial and residential real estate management and development company based in Waltham, Mass. After more than five decades, the business thrives under the day to day management of the founders and second generation of Duffy family members and a team of talented and loyal employees. Duffy Properties offers services including development and acquisition; site selection; permitting; space planning; construction; leasing; and property management. For more information, visit http://www.duffyproperties.com/.
About Cushman & Wakefield
Cushman & Wakefield is a leading global real estate services firm that helps clients transform the way people work, shop, and live. Our 43,000 employees in more than 60 countries help investors optimize the value of their real estate by combining our global perspective and deep local knowledge with an impressive platform of real estate solutions. Cushman & Wakefield is among the largest commercial real estate services firms with revenue of $5 billion across core services of agency leasing, asset services, capital markets, facility services (C&W Services), global occupier services, investment & asset management (DTZ Investors), project & development services, tenant representation, and valuation & advisory. To learn more, visitwww.cushmanwakefield.com or follow @CushWake on Twitter.
